SOOSAN CEBOTICS (017550) Financial Statements

― Followers

SOOSAN CEBOTICS Financial Overview

SOOSAN CEBOTICS's market cap is currently ₩116.81B. The company's EPS TTM is ₩297.3; its P/E ratio is 6.39; and it has a dividend yield of 0.53%. SOOSAN CEBOTICS is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₩ 229.39B	₩ 197.89B	₩ 226.54B	₩ 286.30B	₩ 252.99B
Gross Profit	₩ 51.65B	₩ 48.22B	₩ 52.30B	₩ 64.14B	₩ 48.80B
Operating Income	₩ 19.01B	₩ 12.07B	₩ 19.50B	₩ 22.60B	₩ 14.27B
EBITDA	₩ 25.09B	₩ 19.97B	₩ 27.31B	₩ 27.91B	₩ 21.12B
Net Income	₩ 15.84B	₩ 9.23B	₩ 16.87B	₩ 15.75B	₩ 11.39B
Balance Sheet
Cash & Short-Term Investments	₩ 31.21B	₩ 27.06B	₩ 45.50B	₩ 31.24B	₩ 32.95B
Total Assets	₩ 268.08B	₩ 237.24B	₩ 263.12B	₩ 261.73B	₩ 236.09B
Total Debt	₩ 37.14B	₩ 26.78B	₩ 60.12B	₩ 76.37B	₩ 59.31B
Net Debt	₩ 37.09B	₩ 12.17B	₩ 30.59B	₩ 54.94B	₩ 30.66B
Total Liabilities	₩ 68.45B	₩ 50.99B	₩ 87.61B	₩ 123.18B	₩ 114.04B
Stockholders' Equity	₩ 199.63B	₩ 186.25B	₩ 175.50B	₩ 138.55B	₩ 122.05B
Cash Flow
Free Cash Flow	₩ -1.93B	₩ 14.40B	₩ 7.72B	₩ -8.77B	₩ -8.99B
Operating Cash Flow	₩ 8.65B	₩ 23.24B	₩ 21.45B	₩ 1.58B	₩ -467.36M
Investing Cash Flow	₩ -10.30B	₩ -3.74B	₩ -20.80B	₩ -15.82B	₩ 20.59B
Financing Cash Flow	₩ 8.96B	₩ -35.08B	₩ 7.72B	₩ 8.22B	₩ -17.99B

Currency in KRW

SOOSAN CEBOTICS Earnings and Revenue History

Income Statement >

SOOSAN CEBOTICS Debt to Assets

Balance Sheet >

SOOSAN CEBOTICS Cash Flow

Cash Flow >

SOOSAN CEBOTICS Forecast EPS vs Actual EPS

Earnings >